SEARCH
Quotes News NAV
Quarterly Results Markets  >  Corporate Information  >   Quarterly Results
Alivus Life Sciences Ltd Industry:  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code ISIN Demat Book Value
(R)
NSE
Symbol
Div Yield
%
Market Cap
(Rs.Cr)
P/E
(TTM)
EPS
(TTM)
Face Value
(R)
543322 INE03Q201024 245.7876662 ALIVUS 0.57 10,680.64 20.14 43.23 2
Quarters :
ParticularsSep 2025(Rs.Cr)Jun 2025(Rs.Cr)Mar 2025(Rs.Cr)
Gross Sales587.98601.85649.55
Other Operating Income0.000.000.00
Other Income 14.728.9910.09
Total Income602.70610.83659.63
Total Expenditure 408.81429.54451.11
PBIDT193.89181.30208.52
Interest 1.321.251.26
PBDT192.57180.05207.26
Depreciation18.4417.0615.97
Tax39.9538.9447.88
Fringe Benefit Tax0.000.000.00
Deferred Tax4.162.511.55
Reported Profit After Tax130.03121.54141.87
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item130.03121.54141.87
    
EPS (Unit Curr.)10.609.9111.57
EPS (Adj) (Unit Curr.)10.609.9111.57
Calculated EPS (Unit Curr.)10.239.9111.58
Calculated EPS (Adj) (Unit Curr.)10.239.9111.58
Calculated EPS (Ann.) (Unit Curr.)40.9139.6446.31
Calculated EPS (Adj) (Ann.) (Unit Curr.)40.9139.6446.31
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity25.4324.5324.51
Reserve & Surplus0.000.000.00
Face Value2.002.002.00
    
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
    
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
    
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
    
PBIDTM(%)32.9830.1232.10
PBDTM(%)32.7529.9231.91
PATM(%)22.1120.1921.84